OUR WORK IN
IMMUNO-ONCOLOGY
Cancer Cases Continue to Rise
While global cancer cases continue to rise, the fight is personal – not only for patients and their loved ones but also for those focused on treating cancer and developing new treatments.
14 Million
In 2012, it is estimated that approximately 14 million people worldwide were diagnosed and about 8 million people died from cancer.
20 Million
By 2025, new cancer cases worldwide are predicted to exceed 20 million annually.
Visionary Science: Immuno-Oncology
Today, every member of our team remains committed to smartly and collaboratively accelerating the drug development process and the speed with which we can bring forward new approaches to treat people with cancer.
- Improving Life
- Ethics & Integrity
- Innovation
Immuno-oncology is one of the most exciting areas in cancer research today.
— Gursel Aktan, M.D., Ph.D.
associate vice president, MSD Oncology Clinical Research
MSD is at the forefront of research that we hope could change the way cancer is treated.
— Scot Ebbinghaus, M.D.
executive director, MSD Oncology Clinical Research
We're commited to accelerating every step in the journey from lab to clinic.
— David Kaufman, M.D., Ph.D.
director, MSD Oncology Clinical Research
Understanding the Immune System and Cancer
The Past:
In the 1950s, researchers proposed that the immune system patrols the body to detect and destroy tumor cells. Scientists and researchers had previously focused on cancer cells and treating cancer as a genetic disease.
The Present:
Now the focus is shifting to the microenvironment in which cancer grows, including the immune system – an approach called immuno-oncology.
